HSPG2 and hepatocellular carcinoma: In the 24‐h PLB treatment experiment, PLB inhibited the proliferation of HCC cells in a dose‐dependent manner, and at the inhibition rate of 50%, its concentrations were 7.3 μM for Huh7 cells and 5.2 μM for PLC cells, respectively (Figure 1A).